Ispinesib: Phase Ib data

Data from a Phase Ib study in 24 patients showed the optimally tolerated regimen was 10 mg/m 2 of ispinesib and 60 mg/m 2 of docetaxel treatment for 21 days. About 13 patients had a stable disease res...